Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,687 | 32,284 | 16,373 | 23,442 | 19,302 |
| Marketable Securities | 115,542 | 108,040 | 28,417 | 37,184 | 60,012 |
| TOTAL | $143,457 | $145,564 | $50,727 | $66,516 | $85,257 |
| Non-Current Assets | |||||
| PPE Net | 166 | 1,050 | 1,200 | 1,351 | 1,497 |
| Investments And Advances | 15,147 | 28,783 | 3,494 | 5,838 | 4,232 |
| Other Non-Current Assets | 2,050 | 2,931 | 3,625 | 9,018 | 4,334 |
| TOTAL | $17,363 | $32,764 | $8,319 | $16,207 | $10,063 |
| Total Assets | $160,820 | $178,328 | $59,046 | $82,723 | $95,320 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 5,217 | 5,217 | 4,348 | 3,043 |
| Accounts payable and accrued liabilities | 3,022 | 3,854 | 4,914 | 6,583 | 4,942 |
| Accrued Expenses | 11,754 | 11,107 | 14,422 | 16,791 | 10,863 |
| TOTAL | $14,776 | $20,178 | $24,553 | $27,722 | $18,848 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,705 | 3,295 | 4,532 | 5,764 | 6,997 |
| Other Non-Current Liabilities | 152 | 3,508 | 3,980 | 4,437 | 5,060 |
| TOTAL | $9,857 | $6,803 | $8,512 | $10,201 | $12,057 |
| Total Liabilities | $24,633 | $26,981 | $33,065 | $37,923 | $30,905 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 138,277 | 134,563 | 131,608 | 54,218 | 53,551 |
| Common Shares | 138 | 135 | 54 | 54 | 54 |
| Retained earnings | -758,715 | -740,744 | -722,817 | -699,969 | -677,825 |
| Other shareholders' equity | -224 | -245 | 28 | 43 | 36 |
| TOTAL | $136,187 | $151,347 | $25,981 | $44,800 | $64,415 |
| Total Liabilities And Equity | $160,820 | $178,328 | $59,046 | $82,723 | $95,320 |